Report examines the drivers, barriers, and benefits of using real-world data (RWD) and advanced analytics

Panalgo, a leading healthcare analytics company, today announced the findings of its 2021 State of Healthcare Analytics Benchmarking Report, focused on real-world data (RWD) usage and analytics capabilities at pharmaceutical, biotechnology, and medical device companies worldwide.

This report, based on one of the most extensive surveys of RWD usage in life sciences to date, examines current capabilities of life sciences companies to analyze healthcare data, analytics tools currently being used, barriers to adoption, and progress towards utilizing advanced analytics.

To learn more about the Panalgo 2021 State of Healthcare Analytics Benchmarking Report, click below.